Janux Therapeutics Inc (JANX)
56.71
-0.04
(-0.07%)
USD |
NASDAQ |
Dec 20, 16:00
56.81
+0.10
(+0.18%)
After-Hours: 20:00
Janux Therapeutics Profit Margin (Quarterly): -6.39K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Rezolute Inc | -- |
| Vir Biotechnology Inc | -73.95K% |
| Cytokinetics Inc | -34.67K% |
| Galectin Therapeutics Inc | -- |
| Spero Therapeutics Inc | -219.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -11.37% |
| Return on Assets | -10.65% |
| Return on Invested Capital | -11.37% |
| Operating Margin (Quarterly) | -8.16K% |
| Return on Net Operating Assets | -183.2% |